Meet MILabs @ SNMMI 2023

We’re exhibiting at SNMMI 2023
Let’s meet there!

Be sure to visit us in person at SNMMI 2023, June 24-28 in Chicago, where we’ll have our team on hand to answer questions and discuss your imaging needs. At our booth, we will be presenting MILabs’ latest advancements in synergistic translational PET-SPECT-Optical-CT imaging. Please click here if you would like to schedule a 1:1 meeting with our team

To join the social event in Chicago,
talk to our booth staff and pickup an invitation

MILabs User meeting 2023
Prague or Vienna?

MILabs is planning its annual user meeting in conjunction with a conference in September. This will be either on Monday the 4th of September in Prague, just before the WMIC, or on Wednesday the 19th of September in Vienna, right after the EANM.
Please click this link to indicate your preference.
The purpose of this meeting is to discuss your exciting research and future plans. We will also be sharing our latest updates and developments.

Nobody will see it like you

By scaling up MILabs industry-leading small animal SPECT from mice up to 150kg subjects, G-SPECT will let you see more, with less dose, and provide extra insight with dynamic SPECT. Unlike any other SPECT system, because of a full ring gyro-free detector setup, G-SPECT allows reduced costs on long-term use while offering fast dynamic scanning capabilities with low radiopharmaceutical dose; no elaborate radiopharmaceutical facilities are needed. G-SPECT can handle all new and off-the-shelf diagnostic tracers. But still, it stands out from the crowd with high-resolution theranostic imaging of radiotherapy isotopes, including, e.g., ²²⁵Ac and ¹³¹I targeted alpha and beta particle therapy, respectively, without the need for surrogate marker dosimetry.

Come and talk to our booth staff at SNMMI and learn more about the G-SPECT for large animal imaging.

MILabs launches
ultra-sensitive PET-SPECT

MILabs launches new ultra-sensitive PET and SPECT capabilities for its 7-series imaging platform.
With best-in-the-industry randoms-free sensitivities of up to 15%, these technologies enable the detection of extremely low activities (<0.01 micro-μ) which paves the way for many new applications.For more information please click here and schedule a 1:1 meeting with our team @ SNMMI or virtually.